Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

ESPR holding history

Esperion Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ESPR overviewAll 13F holders of ESPRFull Q2 2026 holdings

Shares (Q2 2026)
259
Value
$818
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of ESPR by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026259$818<0.1%−95,995−99.7%ReducedHolders
Q1 202696,254$263.7K<0.1%−10,430−9.8%ReducedHolders
Q4 2025106,684$394.7K<0.1%−10,740−9.1%ReducedHolders
Q3 2025117,424$311.2K<0.1%−10,000−7.8%ReducedHolders
Q2 2025127,424$125.4K<0.1%+117,424+1,174.2%AddedHolders
Q1 202510,000$14.4K<0.1%00.0%UnchangedHolders
Q4 202410,000$22.0K<0.1%−234,000−95.9%ReducedHolders
Q3 2024244,000$402.6K<0.1%+5,000+2.1%AddedHolders
Q2 2024239,000$530.6K<0.1%00.0%UnchangedHolders
Q1 2024239,000$640.5K<0.1%−239,000−50.0%ReducedHolders
Q4 2023478,000$1.43M<0.1%00.0%UnchangedHolders
Q3 2023478,000$468.4K<0.1%+478,000NewHolders
Q2 20230$00.0%−169−100.0%Sold outHolders
Q1 2023169$269<0.1%+169NewHolders
Q4 20220$00.0%−53−100.0%Sold outHolders
Q3 202253$00.0%+18+51.4%AddedHolders
Q2 202235$00.0%+35NewHolders
Q1 20220$00.0%−1,526−100.0%Sold outHolders
Q4 20211,526$8.00K<0.1%+1,400+1,111.1%AddedHolders
Q3 2021126$2.00K<0.1%+124+6,200.0%AddedHolders
Q2 20212$00.0%00.0%UnchangedHolders
Q1 20212$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.